The central bank’s highly anticipated rate decision is due Wednesday, and money market funds’ yields are about to take a hit.
A growth stock showing signs of a breakout even as investors rotate out of group before Fed
Todd Gordon breaks down the charts in Meta.
How to invest for the next decade with New York Life’s Lauren Goodwin from Future Proof 2024
With interest rates likely to remain volatile, here is where New York Life’s Lauren Goodwin sees opportunities.
Op-ed: Here’s why a sale of Bausch + Lomb could lead to a windfall for Bausch Health investors
Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don’t think like your typical corporate board, writes Ken Squire of 13D Monitor.
A hedge that pays off if the chip stock comeback isn’t for real
Nishant Pant looks at a bearish options trade on Broadcom into the Fed decision.
Analysts say don’t chase this Intel pop here
Wall Street analysts are still skeptical on Intel despite its latest moves aimed at righting the ship.
UBS says get defensive as global growth disappoints. Gives stocks to buy
As global growth slows, UBS is staying overweight on defensive names, unveiling a list of top buy-rated stocks.
Here are Tuesday’s biggest analyst calls: Nvidia, Palantir, Amazon, Shopify, Walmart, Microsoft, Palantir, Tesla & more
Here are Tuesday’s biggest calls on Wall Street.
Tuesday’s analyst calls: Micron price target cut, e-commerce stock to pop nearly 35%
A chipmaker and an e-commerce giant were among the stocks being talked about by analysts on Tuesday.
Tuesday’s big stock stories: What’s likely to move the market in the next trading session
On Monday, the S&P 500 ticked higher and the 30-stock Dow closed at a record. What CNBC is watching going into Tuesday.